Project Grant H8G47742

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...

This $799,904 Cooperative Agreement award, granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), supports research and activities by New York University (NYU) School of Medicine to study vaccine hesitancy and uptake. The award, effective from September 30, 2024 through September 29, 2029, will enable NYU to serve as a coordinating and collaborating center for this CDC initiative, which...

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This federal Project Grant award of $442,478.00, awarded by the National Science Foundation (NSF) under the Social, Behavioral, and Economic Sciences (CFDA 47.075) program, supports a multi-modal study on sociodemographic influences on vaccine decision-making. The research team, led by the University of California, Los Angeles (UCLA) with a sub-award to Arizona State University (ASU), will examine how local illness models, individual factors, sociodemographic characteristics, and social learning...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program provides $5,358,220.00 to the Hawaii Department of Health to increase vaccination rates in the state, with a focus on populations disproportionately affected by monkeypox (MPOX). The funding will support the creation and maintenance of a multi-divisional workgroup within the Hawaii Department of...

This $737,761.00 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) aims to enhance HIV prevention with a vaccine approach that promotes durable immunity. The key products and services to be delivered include: Detailed immune analyses to uncover mechanisms of effective T follicular helper (Tfh) cell-mediated humoral immunity against HIV, using both DNA and mRNA vaccine platforms in rhesus macaques. The...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $282,526 Cooperative Agreement under the Immunization Cooperative Agreements (CFDA 93.268) program to the South Carolina Department of Public Health (SCDPH) to administer the Behavioral Risk Factor Surveillance System in South Carolina. The 5-year award, effective August 1, 2024 through July 31, 2029, will fund SCDPH's efforts to establish and maintain preventive health service programs focused on immunizing individuals...

The Centers for Disease Control and Prevention (CDC) awarded a five-year, $48,244,515 Cooperative Agreement to the Virginia State Board of Health (VA SBOH) through the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421). This grant funding will support VA SBOH's Office of Emergency Preparedness Division in delivering a range of critical public health, emergency response, and social service programs across...

This $820,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "CDC Investigations and Technical Assistance" program (CFDA 93.283) will support "Strengthening Routine Immunization and Vaccine Equity (STRIVE)" activities in the Democratic Republic of the Congo and Brazil. The 5-year project, with a period of performance from September 30, 2024 to September 29, 2029, will be implemented by the non-profit organization World Vision...